Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Tofacitinib may help regrow hair in severe alopecia areata, but results differ greatly between people.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Using a laser with bimatoprost solution works better for hair regrowth in alopecia areata than bimatoprost alone.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.